Cleared Traditional

K925701 - MINIPACK 911-STC

K925701 is the FDA 510(k) clearance for MINIPACK 911-STC by Pace Tech, Inc.. It is a Class 2 Anesthesiology device (product code CCK) cleared through the Traditional 510(k) pathway after a 637-day FDA review.

K925701 · Pace Tech, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1994
Decision
637d
Days
Class 2
Risk

K925701 is an FDA 510(k) clearance for the MINIPACK 911-STC. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Pace Tech, Inc. (Clearwater, US). The FDA issued a Cleared decision on August 11, 1994 after a review of 637 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Pace Tech, Inc. devices

Submission Details

510(k) Number K925701 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 12, 1992
Decision Date August 11, 1994
Days to Decision 637 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
497d slower than avg
Panel avg: 140d · This submission: 637d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 80
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K925701.
SMART ANESTHESIA MULTI-GAS (SAM) MODULE
K950581 · Marquette Electronics, Inc. · Mar 1995
SMART ANESTHESIA MULTI-GAS (SAM) MODULE
K943977 · Marquette Electronics, Inc. · Mar 1995
SIDESTREAM PUMP PLUG-IN MODULE OF COMPONENT MONITORING SYSTEM
K943389 · Hewlett-Packard Co. · Mar 1995
HP M1465A STANDARD AIRWAY ADAPTER
K933980 · Hewlett-Packard Co. · Sep 1993
RASCAL II
K930866 · Ohmeda Medical · May 1993
MASS SPECTROMETRY MONITORING LINE CONONECTORS
K925167 · Merit Medical Systems, Inc. · Jan 1993